{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:13:24Z","timestamp":1784841204272,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.contraception.2007.01.002","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T12:16:34Z","timestamp":1172060194000},"page":"S60-S69","source":"Crossref","is-referenced-by-count":52,"special_numbering":"S","title":["Neoplasia with use of intrauterine devices"],"prefix":"10.1016","volume":"75","author":[{"given":"Kathryn M.","family":"Curtis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly A.","family":"Marchbanks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert B.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2007.01.002_bib1","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1016\/S0010-7824(98)00082-1","article-title":"Intrauterine devices: mechanisms of action, safety, and efficacy","volume":"58","author":"Mishell","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.002_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/07853899009147248","article-title":"Levonorgestrel-releasing intrauterine device","volume":"22","author":"Luukkainen","year":"1990","journal-title":"Ann Med"},{"key":"10.1016\/j.contraception.2007.01.002_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jclinepi.2003.12.001","article-title":"Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors","volume":"57","author":"Schmid","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.contraception.2007.01.002_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.2910490108","article-title":"A population-based case\u2013control study of endometrial cancer in Shanghai, China","volume":"49","author":"Shu","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2007.01.002_bib5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ijc.2910540607","article-title":"Intra-uterine contraception and the risk of endometrial cancer","volume":"54","author":"Castellsague","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2007.01.002_bib6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/bjc.1994.369","article-title":"Intrauterine device use and risk of endometrial cancer","volume":"70","author":"Parazzini","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.contraception.2007.01.002_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0010-7824(96)00199-0","article-title":"Intrauterine devices and endometrial cancer","volume":"54","author":"Rosenblatt","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.002_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ije\/26.3.496","article-title":"Intrauterine device use and endometrial cancer risk","volume":"26","author":"Sturgeon","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.contraception.2007.01.002_bib9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/(SICI)1097-0215(19970127)70:3<278::AID-IJC5>3.0.CO;2-U","article-title":"Endometrial cancer in relation to intra-uterine device use","volume":"70","author":"Hill","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2007.01.002_bib10","first-page":"3658","article-title":"Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico","volume":"59","author":"Salazar-Martinez","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.contraception.2007.01.002_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0301-2115(02)00153-7","article-title":"IUD use and the risk of endometrial cancer","volume":"105","author":"Benshushan","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2007.01.002_bib12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10552-006-0034-6","article-title":"Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women","volume":"17","author":"Wernli","year":"2006","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.contraception.2007.01.002_bib13","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/ijc.22081","article-title":"Oral contraceptive and IUD use and endometrial cancer: a population-based case\u2013control study in Shanghai, China","volume":"119","author":"Tao","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2007.01.002_bib14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0010-7824(03)00003-9","article-title":"Survey of IUD replacing status in Sichuan, PR China","volume":"67","author":"Xiaoqin","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.002_bib15","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/humrep\/17.5.1226","article-title":"Socio-demographic determinants of intrauterine device use and failure in China","volume":"17","author":"Wang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2007.01.002_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9378(76)90569-X","article-title":"Carcinoma of the cervix in oral contraceptive steroid and IUD users and nonusers","volume":"125","author":"Sandmire","year":"1976","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.002_bib17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/ije\/20.4.865","article-title":"Invasive cervical cancer and intrauterine device use","volume":"20","author":"Lassise","year":"1991","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.contraception.2007.01.002_bib18","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/ije\/21.5.1030","article-title":"Use of intrauterine device and risk of invasive cervical cancer","volume":"21","author":"Parazzini","year":"1992","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.contraception.2007.01.002_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/152460900318498","article-title":"Tubal sterilization and use of an IUD and risk of cervical cancer","volume":"9","author":"Li","year":"2000","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.contraception.2007.01.002_bib20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.AOG.0000178754.88912.b9","article-title":"Use of the levonorgestrel-releasing intrauterine system and breast cancer","volume":"106","author":"Backman","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.002_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0002-9378(89)90248-2","article-title":"Gestational trophoblastic disease: a case\u2013control study from the People's Republic of China","volume":"161","author":"Brinton","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.002_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0010-7824(86)90074-0","article-title":"The intrauterine contraceptive device and hydatidiform mole: a negative association","volume":"34","author":"Honore","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.002_bib23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0002-9378(83)90494-5","article-title":"Relationship of oral contraceptives and the intrauterine contraceptive devices to the regression of concentrations of the beta subunit of human chorionic gonadotropin and invasive complications after molar pregnancy","volume":"145","author":"Ho Yuen","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.002_bib24","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1158\/1055-9965.EPI-05-0493","article-title":"Inflammation and endometrial cancer: a hypothesis","volume":"14","author":"Modugno","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.contraception.2007.01.002_bib25","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/humrep\/12.9.1851","article-title":"Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis","volume":"12","author":"Schlesselman","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2007.01.002_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2007.01.002_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1447-0756.2004.00182.x","article-title":"Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: can Cu-T prevent endometrial cancer?","volume":"30","author":"Guleria","year":"2004","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.contraception.2007.01.002_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0010-7824(87)90058-8","article-title":"Mechanism of action of intrauterine devices: biochemical changes","volume":"36","author":"Johannisson","year":"1987","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.002_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/canjclin.56.2.69","article-title":"Chronic inflammation: a common and important factor in the pathogenesis of neoplasia","volume":"56","author":"Schottenfeld","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.contraception.2007.01.002_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/0470856734.ch2","article-title":"Inflammation and cancer: an epidemiological perspective","volume":"256","author":"Thun","year":"2004","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.contraception.2007.01.002_bib31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0015-0282(16)41950-3","article-title":"The mechanism of action of the copper intrauterine device","volume":"27","author":"Tamaya","year":"1976","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2007.01.002_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1677\/joe.0.0870365","article-title":"Alterations in progesterone receptors in the rat uterus bearing an intra-uterine device during the oestrous cycle and early pregnancy","volume":"87","author":"Myatt","year":"1980","journal-title":"J Endocrinol"},{"key":"10.1016\/j.contraception.2007.01.002_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0015-0282(99)00162-4","article-title":"The levonorgestrel intrauterine system in menopausal hormone replacement therapy: five-year experience","volume":"72","author":"Suvanto-Luukkonen","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2007.01.002_bib34","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(00)03204-9","article-title":"Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial","volume":"356","author":"Gardner","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2007.01.002_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/13625189709165300","article-title":"Precancerous lesions of the endometrium and medical treatment","volume":"2","author":"Taddei","year":"1997","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2007.01.002_bib36","first-page":"284","article-title":"Levonorgestrel Nova-T and precancerous lesions of the endometrium","volume":"9","author":"Scarselli","year":"1988","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.contraception.2007.01.002_bib37","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1067\/mob.2003.346","article-title":"Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system","volume":"188","author":"Wildemeersch","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.002_bib38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mob.2002.122130","article-title":"Intrauterine progesterone treatment of early endometrial cancer","volume":"186","author":"Montz","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.01.002_bib39","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ygyno.2004.10.031","article-title":"Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature","volume":"97","author":"Dhar","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.contraception.2007.01.002_bib40","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/S0010-7824(15)30002-0","article-title":"Breast cancer and hormonal contraceptives: further results","volume":"54","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.002_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0010-7824(01)00188-3","article-title":"Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health","volume":"63","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.002_bib42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.contraception.2003.12.015","article-title":"Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer","volume":"69","author":"Strom","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.01.002_bib43","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/bmj.299.6702.759","article-title":"Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer","volume":"299","author":"Paul","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2007.01.002_bib44","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0140-6736(91)91498-J","article-title":"Breast cancer and depot-medroxyprogesterone acetate: a multinational study","volume":"338","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2007.01.002_bib45","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/oxfordjournals.aje.a010219","article-title":"Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen\/progestogen contraceptives","volume":"151","author":"Shapiro","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2007.01.002_bib46","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.273.10.799","article-title":"Depot medroxyprogesterone acetate and breast cancer. A pooled analysis of the World Health Organization and New Zealand studies","volume":"273","author":"Skegg","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2007.01.002_bib47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002018-200326050-00002","article-title":"Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants","volume":"26","author":"Sivin","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.contraception.2007.01.002_bib48","first-page":"381","article-title":"Pharmacokinetics of depot medroxyprogesterone acetate contraception","volume":"41","author":"Mishell","year":"1996","journal-title":"J Reprod Med"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782407000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782407000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T06:22:44Z","timestamp":1547014964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782407000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0010782407000315"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2007.01.002","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}